Pål Kristian Selbo receives NOK 3.75 million from Radforsk Investment Foundation
Radforsk Investment Foundation has granted five research projects a total amount of MNOK 4.95 to further develop exciting research projects within photodynamic treatment and photochemical internalization.
This year, one of the projects has been awarded a total of NOK 3.75 million over three years. It is a project led by researcher Pål Selbo from the Department of Radiation Biology at Institute for Cancer Research entitled «Novel Photobiological Strategies Counteracting Tumor Immune Escape».
Selbo has been interviewed (in Norwegian) for the Radium podcast on basis of the Radforsk support.
From the Radforsk home page:
Radforsk Investment Foundation is an evergreen investor focusing on companies that develop cancer treatment.
‘Radforsk has ploughed NOK 205 million of its profit back into cancer research at Oslo University Hospital. Of these, NOK 32 million, have gone to research in PDT/PCI. This year we grant five projects a total of NOK 4.95 million,’ says Jónas Einarsson, CEO of Radforsk Investment Foundation.
Radforsk had received a total of six applications by the deadline of 15. January 2021. The applications have been assessed by external experts.
This year, one of the projects has been awarded a total of NOK 3.75 million over three years. It is a project led by researcher Pål Selbo at the Department of Cancer Research entitled «Novel Photobiological Strategies Counteracting Tumor Immune Escape».
‘This is exciting research with the aim of applying PCI technology in issues such as immunotherapy. Pål has extensive experience as a researcher in the field, so it’s fun that he went all the way to the top with this application,’ says Einarsson.
‘It is fantastic and very motivating to receive such great support from Radforsk. This means that I can finally realize this project,’ says Pål Selbo.
The researchers who have received funding for PDT/PCI research in 2021 are:
Pål Kristian Selbo
Cancer research in the field of photodynamic therapy and photochemical internalisation studies the use of light in direct cancer treatment in combination with drugs, or to deliver drugs that can treat cancer to cells or organs.
The original news article from the Radforsk home page:
Pål Selbo til topps i PCI/PDT tildeling
Radium podcast: "Pål Selbo og PCI Biotech" (on Soundcloud).
Can also be streamed by using iTunes, Acast and Spotify.
Pål Kristian Selbo's project group:
Light-controlled delivery of cancer immunotherapeutics
Kristian Berg's group:
Photochemical internalisation (PCI)